conflict of interest
Major
health insurance companies own nearly $4.5 billion worth of stock in tobacco companies, according to a Harvard University study. It kinda makes sense: health insurers know tobacco sickens people, and so as long as people are smoking, why not profit from the killer? It's what David Himmelstein, a co-author of the study, calls "the combined taxidermist and veterinarian approach: either way you get your dog back."
More »
conflict of interest
CT scanning, a promising approach to detecting lung cancer at early, treatable stages, has been dealt a setback with the revelation that the most prominent study so far in support of it
was funded almost entirely by a cigarette company—with the funds funneled through a foundation set up by the study's author, Dr. Claudia Henschke, reports the New York Times. Although the funding revelation doesn't negate the results of the study, it raises huge conflict of interest flags and reveals how a tobacco company secretly influenced professional opinion by funneling $3.6 million into the foundation over a three year period.
More »
safety
The
FDA yanked the heart surgery drug Trasylol off the market last November, but a medical researcher now claims that 22,000 lives could have been saved if Bayer AG hadn't withheld the results of an earlier internal study proving the drug's danger. An FDA committee held hearings in September 2006 to determine Trasylol's safety, but three of the committee members had a financial interest in Bayer, and the drug maker had underwritten the committee chairman's research.
More »
Consumerist
conflict of interest
conflict of interest
